- In December 2023, Roflumilast topical foam 0.3% received approval from the U.S. Food & Drug Administration (FDA) for treating Seborrheic Dermatitis in patients aged nine years and older, further strengthening advancements in dermatological foam therapies
- In September 2023, Tristel sought regulatory certification for its Tristel ULT disinfection foam, with Parker Laboratories, Tristel’s North American partner, responsible for manufacturing, marking a significant step toward expanding disinfection solutions in healthcare
- In May 2023, Probo Medical successfully acquired the MRI coil repair operation from Creative Foam, enabling in-house complex MRI coil repairs and enhancing customer satisfaction and operational efficiency in diagnostic imaging
- In January 2023, Convatec launched ConvaFoam, an innovative foam dressing designed for versatile wound management and skin protection, simplifying clinical applications across various stages of the healing process
- In March 2022, Foamtec Medical introduced BactiBlock Antimicrobial Foam, a medical-grade foam infused with antimicrobial agents, providing a solution to reduce infection risks in healthcare environments
